SR1078 (Synonyms: SR 1078;SR-1078) |
| رقم الكتالوجGC16392 |
SR1078 is an agonist of the retinoic acid receptor-related orphan receptors (RORs) RORα and RORγ, with IC50 values of 1-3µM.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1246525-60-9
Sample solution is provided at 25 µL, 10mM.
SR1078 is an agonist of the retinoic acid receptor-related orphan receptors (RORs) RORα and RORγ, with IC50 values of 1-3µM[1]. SR1078 can directly bind to the ligand binding domains of RORα and RORγ, increasing the transcriptional activity of these receptors, thereby stimulating the transcription of RORα/γ target genes[2, 3]. SR1078 can regulate osteoblast metabolism through anti-inflammatory effects[4].
In vitro, SR1078 (2-10µM) treatment of human neuroblastoma SH-SY5Y cells for 24h increased the expression of A2BP1, CYP19A1, NLGN1 and IPTR1 genes in the cells in a dose-dependent manner, with an EC50 range of 3-5μM[5]. SR1078 (1, 5µM) treatment of HepG2 cells increased the expression of p53 protein and induced cell apoptosis[6].
In vivo, SR1078 (20mg/kg) was intraperitoneally injected into mice bearing colorectal cancer cell xenografts, significantly inhibiting the growth of subcutaneous tumors and the metastasis of tumor cells[7].
References:
[1] Wang Y, Kumar N, Nuhant P, et al. Identification of SR1078, a synthetic agonist for the orphan nuclear receptors RORα and RORγ[J]. ACS chemical biology, 2010, 5(11): 1029-1034.
[2] Kamenecka T M, Lyda B, Chang M R, et al. Synthetic modulators of the retinoic acid receptor-related orphan receptors[J]. MedChemComm, 2013, 4(5): 764-776.
[3] Nematisouldaragh D, Kirshenbaum E, Uzonna M, et al. The Role of Retinoic-Acid-Related Orphan Receptor (RORs) in Cellular Homeostasis[J]. International Journal of Molecular Sciences, 2024, 25(21): 11340.
[4] Fernandes J, Benderdor M, Shi Q. SR1078, A synthetic ligand of nuclear receptor ror alpha, modulates osteoblast metabolism with anti-inflammatory effects[J]. Osteoarthritis and Cartilage, 2012, 20: S115-S116.
[5] Wang Y, Billon C, Walker J K, et al. Therapeutic effect of a synthetic RORα/γ agonist in an animal model of autism[J]. ACS Chemical Neuroscience, 2016, 7(2): 143-148.
[6] Wang Y, Solt L A, Kojetin D J, et al. Regulation of p53 stability and apoptosis by a ROR agonist[J]. PloS one, 2012, 7(4): e34921.
[7] Wang Y N, Ruan D Y, Wang Z X, et al. Targeting the cholesterol-RORα/γ axis inhibits colorectal cancer progression through degrading c-myc[J]. Oncogene, 2022, 41(49): 5266-5278.
| Cell experiment [1]: | |
Cell lines | SH-SY5Y cells |
Preparation Method | SH-SY5Y were treated with SR1078 (2-10µM), and after 24h cells were harvested and cDNA prepared to assess the expression of autism spectrum disorder (ASD)-associated genes by quantitative PCR. |
Reaction Conditions | 2-10µM; 24h |
Applications | SR1078 increases the expression of ASD-associated genes in SH-SY5Y cells. SR1078 treatment increased the expression of A2BP1, CYP19A1, NLGN1, and IPTR1 in a dose-dependent manner with EC50 ranging from 3-5μM. |
| Animal experiment [2]: | |
Animal models | Female BALB/c athymic nude mice |
Preparation Method | To establish the subcutaneous tumour model, 2×106 CRC cells were suspended in 100μL PBS and then injected subcutaneously. Tumour volumes were measured every 3 or 4 days with a caliper and were calculated. For the drug treatment studies, daily doses of 20mg/kg atorvastatin, 20mg/kg SR1078 or the combination were administered via intraperitoneal (i.p.) injection. After the mice were euthanized, the tumours were excised and weighed. |
Dosage form | 20mg/kg; i.p. |
Applications | SR1078 significantly inhibited tumour growth in nude mice subcutaneously. |
References: | |
| Cas No. | 1246525-60-9 | SDF | |
| المرادفات | SR 1078;SR-1078 | ||
| Chemical Name | N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-4-(trifluoromethyl)benzamide | ||
| Canonical SMILES | C1=CC(=CC=C1C(=O)NC2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O)C(F)(F)F | ||
| Formula | C17H10F9NO2 | M.Wt | 431.25 |
| الذوبان | ≥ 43.2 mg/mL in DMSO, ≥ 43.4 mg/mL in EtOH | Storage | Store at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 2.3188 mL | 11.5942 mL | 23.1884 mL |
| 5 mM | 463.8 μL | 2.3188 mL | 4.6377 mL |
| 10 mM | 231.9 μL | 1.1594 mL | 2.3188 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
- Purity: >99.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *